Press Play with Madeleine Brand
Diabetes drug Ozempic is costing Medicare billions of dollars
New analysis from the Kaiser Family Foundation shows that Medicare spending on weight loss drugs like Ozempic rose to $5.7 billion in 2022 — up from $57 million in 2018.
New analysis from the Kaiser Family Foundation shows that Medicare spending on weight loss drugs like Ozempic rose to $5.7 billion in 2022 — up from $57 million in 2018.
The full episode
1 of 5- 0:00Diabetes drug Ozempic is costing Medicare billions of dollarsYou’re reading this
- 8:37Hollywood Boulevard: Expect more room for cyclists, walkers, buses
- 17:24Ebony Beach Club: Will Silas White’s descendants get restitution?
- 26:24How to build meaningful connections in an age of isolation
- 41:16Flowering vegetables? Don’t trash them, they’re still edible